-
Product Insights
NewMonoamine Oxidase – Drugs In Development, 2024
The Monoamine Oxidase pipeline drugs market research report outlays comprehensive information on the Monoamine Oxidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Infectious Disease, Oncology, and Immunology which include indications of Parkinson's Disease, Alzheimer's Disease, Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome, Coronavirus Disease 2019 (COVID-19) Pneumonia, Glioma, and Autoimmune Disorders. It...
-
Product Insights
NewCeramide Glucosyltransferase – Drugs In Development, 2024
The Ceramide Glucosyltransferase pipeline drugs market research report outlays comprehensive information on the Ceramide Glucosyltransferase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Genetic Disorders, Central Nervous System, and Oncology which include indications of Fabry Disease, Sandhoff Disease (Jatzkewitz-Pilz Syndrome), Tay-Sachs Disease, Polycystic Kidney Disease, Parkinson's Disease, Neuropathy, Solid Tumor, and Bile Duct Cancer (Cholangiocarcinoma)...
-
Product Insights
NewMucolipin 1 – Drugs In Development, 2024
The Mucolipin 1 pipeline drugs market research report outlays comprehensive information on the Mucolipin 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, Undisclosed, and Musculoskeletal Disorders which include indications of Neurodegenerative Diseases, Parkinson's Disease, Lysosomal Storage Disorder, Niemann-Pick Disease Type C, Unspecified Rare Disease, and Muscular Dystrophy. It also reviews key...
-
Product Insights
NewCasein Kinase 2 – Drugs In Development, 2024
The Casein Kinase 2 pipeline drugs market research report outlays comprehensive information on the Casein Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, and Infectious Disease which include indications of Lung Cancer, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Huntington Disease, Neurodegenerative Diseases, Coronavirus Disease 2019 (COVID-19), and Community Acquired Pneumonia....
-
Product Insights
NewPhosphodiesterase 9 – Drugs In Development, 2024
The Phosphodiesterase 9 pipeline drugs market research report outlays comprehensive information on the Phosphodiesterase 9 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Hematological Disorders, and Undisclosed which include indications of Congestive Heart Failure (Heart Failure), Systolic Heart Failure, Alzheimer's Disease, Parkinson's Disease, Sickle Cell Disease, Thalassemia, and Unspecified Rare Disease. It also...
-
Product Insights
NewProtein O GlcNAcase – Drugs In Development, 2024
The Protein O GlcNAcase pipeline drugs market research report outlays comprehensive information on the Protein O GlcNAcase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, and Genetic Disorders which include indications of Alzheimer's Disease, Parkinson's Disease, Sandhoff Disease (Jatzkewitz-Pilz Syndrome), and Tay-Sachs Disease. It also reviews key players involved in Protein O...
-
Product Insights
NewCytochrome b 245 Heavy Chain – Drugs In Development, 2024
The Cytochrome b 245 Heavy Chain pipeline drugs market research report outlays comprehensive information on the Cytochrome b 245 Heavy Chain targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Genetic Disorders, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Chronic Granulomatous Disease, Cardiovascular Disease, Pulmonary Hypertension, Alzheimer's Disease, Epilepsy, and Influenzavirus A Infections. It...
-
Product Insights
NewCholesteryl Ester Transfer Protein – Drugs In Development, 2024
The Cholesteryl Ester Transfer Protein pipeline drugs market research report outlays comprehensive information on the Cholesteryl Ester Transfer Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Dyslipidemia, Heterozygous familial hypercholesterolemia (heFH), Cardiovascular, Cardiovascular Disease, Alzheimer's Disease, and Coronavirus Disease 2019 (COVID-19). It also...
-
Product Insights
NewGlucosylceramidase – Drugs In Development, 2024
The Glucosylceramidase pipeline drugs market research report outlays comprehensive information on the Glucosylceramidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Central Nervous System which include indications of Gaucher Disease, Gaucher Disease Type I, Parkinson's Disease, and Lewy Body Dementia. It also reviews key players involved in Glucosylceramidase targeted therapeutics development with respective active...
-
Product Insights
NewAlpha Glucosidase – Drugs In Development, 2024
The Alpha Glucosidase pipeline drugs market research report outlays comprehensive information on the Alpha Glucosidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Central Nervous System which include indications of Pompe Disease, and Lafora Disease (Unverricht Disease). It also reviews key players involved in Alpha Glucosidase targeted therapeutics development with respective active and dormant...